Submitted by Anonymous (not verified) on 20 November 2023 - 10:09
Human medicines European public assessment report (EPAR): Mylotarg, gemtuzumab ozogamicin, Leukemia, Myeloid, Acute, Date of authorisation: 19/04/2018, Revision: 12, Status: Authorised
Source: